Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

Boehringer Ingelheim

Status: Completed

Conditions: Parkinson Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01100073

248.657

Details and patient eligibility

About

The study will compare the effect of pramipexole on different types of tremor and particularly kinetic tremor in early and advanced Parkinson's disease patients and will evaluate the course of tremor measured with spiralometry under pramipexole treatment.

Enrollment: 1,703 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Idiopathic Parkinson's disease with or without fluctuations
2. Indication for treatment with pramipexole (Mirapexin®)
3. Presence of at least mild tremor symptoms (as judged by the treating physician)

Exclusion criteria

1. Any contraindications according to the Summary of Product Characteristics (SPC): hypersensitivity to pramipexole or to any of the excipients.
2. Ongoing treatment with pramipexole (Mirapexin®)

Trial design

1,703 participants in 1 patient group

Patients with Parkinson's disease

Description:

Early and advanced Parkinson's disease patients